{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:23:52Z","timestamp":1790447032884,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T00:00:00Z","timestamp":1473379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T00:00:00Z","timestamp":1473379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Inherited aortopathy, which is characterized by a high risk of fatal aortic aneurysms\/dissections, can occur secondarily to several syndromes. To identify genetic mutations and help make a precise diagnosis, we designed a gene panel containing 15 genes responsible for inherited aortopathy and tested 248 probands with aortic disease or Marfan syndrome. The results showed that 92 individuals (37.1%) tested positive for a (likely) pathogenic mutation, most of which were <jats:italic>FBN1<\/jats:italic> mutations. We found that patients with a <jats:italic>FBN1<\/jats:italic> truncating or splicing mutation were more prone to developing severe aortic disease or valvular disease. To date, this is the largest reported cohort of Chinese patients with aortic disease who have undergone genetic testing. Therefore, it can serve as a considerable dataset of next generation sequencing data analysis of Chinese population with inherited aortopathy. Additionally, according to the accumulated data, we optimized the analysis pipeline by adding quality control steps and lowering the false positive rate.<\/jats:p>","DOI":"10.1038\/srep33002","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T14:46:41Z","timestamp":1473432401000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Genetic testing of 248 Chinese aortopathy patients using a panel assay"],"prefix":"10.1038","volume":"6","author":[{"given":"Hang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yandong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunlun","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenke","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunjie","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,9]]},"reference":[{"key":"BFsrep33002_CR1","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/0002-8703(58)90197-2","volume":"56","author":"KP Sinha","year":"1958","unstructured":"Sinha, K. P. & Goldberg, H. Marfan\u2019s syndrome: a case with complete dissection of the aorta. Am Heart J 56, 890\u2013897 (1958).","journal-title":"Am Heart J"},{"key":"BFsrep33002_CR2","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1056\/NEJMoa055695","volume":"355","author":"BL Loeys","year":"2006","unstructured":"Loeys, B. L. et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med 355, 788\u2013798 (2006).","journal-title":"N Engl J Med"},{"key":"BFsrep33002_CR3","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1056\/NEJM200003093421001","volume":"342","author":"M Pepin","year":"2000","unstructured":"Pepin, M., Schwarze, U., Superti-Furga, A. & Byers, P. H. Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med 342, 673\u2013680 (2000).","journal-title":"N Engl J Med"},{"key":"BFsrep33002_CR4","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/ng.2421","volume":"44","author":"AJ Doyle","year":"2012","unstructured":"Doyle, A. J. et al. Mutations in the TGF-beta repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysm. Nat Genet 44, 1249\u20131254 (2012).","journal-title":"Nat Genet"},{"key":"BFsrep33002_CR5","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/0735-1097(89)90221-0","volume":"13","author":"P Nicod","year":"1989","unstructured":"Nicod, P. et al. Familial aortic dissecting aneurysm. J Am Coll Cardiol 13, 811\u2013819 (1989).","journal-title":"J Am Coll Cardiol"},{"key":"BFsrep33002_CR6","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S0741-5214(95)70227-X","volume":"21","author":"G Johansson","year":"1995","unstructured":"Johansson, G., Markstrom, U. & Swedenborg, J. Ruptured thoracic aortic aneurysms: a study of incidence and mortality rates. J Vasc Surg 21, 985\u2013988 (1995).","journal-title":"J Vasc Surg"},{"key":"BFsrep33002_CR7","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1161\/CIRCULATIONAHA.113.001457","volume":"127","author":"FS Schoenhoff","year":"2013","unstructured":"Schoenhoff, F. S. et al. Acute aortic dissection determines the fate of initially untreated aortic segments in Marfan syndrome. Circulation 127, 1569\u20131575 (2013).","journal-title":"Circulation"},{"key":"BFsrep33002_CR8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/352337a0","volume":"352","author":"HC Dietz","year":"1991","unstructured":"Dietz, H. C. et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 352, 337\u2013339 (1991).","journal-title":"Nature"},{"key":"BFsrep33002_CR9","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/ng1511","volume":"37","author":"BL Loeys","year":"2005","unstructured":"Loeys, B. L. et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet 37, 275\u2013281 (2005).","journal-title":"Nat Genet"},{"key":"BFsrep33002_CR10","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1161\/CIRCRESAHA.111.248161","volume":"109","author":"ES Regalado","year":"2011","unstructured":"Regalado, E. S. et al. Exome sequencing identifies SMAD3 mutations as a cause of familial thoracic aortic aneurysm and dissection with intracranial and other arterial aneurysms. Circ Res 109, 680\u2013686 (2011).","journal-title":"Circ Res"},{"key":"BFsrep33002_CR11","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1038\/ng.2349","volume":"44","author":"ME Lindsay","year":"2012","unstructured":"Lindsay, M. E. et al. Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm. Nat Genet 44, 922\u2013927 (2012).","journal-title":"Nat Genet"},{"key":"BFsrep33002_CR12","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/BF00284038","volume":"82","author":"A Superti-Furga","year":"1989","unstructured":"Superti-Furga, A., Steinmann, B., Ramirez, F. & Byers, P. H. Molecular defects of type III procollagen in Ehlers-Danlos syndrome type IV. Hum Genet 82, 104\u2013108 (1989).","journal-title":"Hum Genet"},{"key":"BFsrep33002_CR13","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/ajmg.a.31514","volume":"143A","author":"B Drera","year":"2007","unstructured":"Drera, B. et al. Two novel SLC2A10\/GLUT10 mutations in a patient with arterial tortuosity syndrome. Am J Med Genet A 143A, 216\u2013218 (2007).","journal-title":"Am J Med Genet A"},{"key":"BFsrep33002_CR14","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.jtcvs.2014.07.070","volume":"149","author":"DM Milewicz","year":"2015","unstructured":"Milewicz, D. M. & Regalado, E. S. Use of genetics for personalized management of heritable thoracic aortic disease: how do we get there? J Thorac Cardiovasc Surg 149, S3\u2013S5 (2015).","journal-title":"J Thorac Cardiovasc Surg"},{"key":"BFsrep33002_CR15","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1002\/ajmg.a.37085","volume":"167A","author":"W Wooderchak-Donahue","year":"2015","unstructured":"Wooderchak-Donahue, W. et al. Clinical utility of a next generation sequencing panel assay for Marfan and Marfan-like syndromes featuring aortopathy. Am J Med Genet A 167A, 1747\u20131757 (2015).","journal-title":"Am J Med Genet A"},{"key":"BFsrep33002_CR16","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/humu.22802","volume":"36","author":"D Proost","year":"2015","unstructured":"Proost, D. et al. Performant Mutation Identification Using Targeted Next-Generation Sequencing of 14 Thoracic Aortic Aneurysm Genes. Hum Mutat 36, 808\u2013814 (2015).","journal-title":"Hum Mutat"},{"key":"BFsrep33002_CR17","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1086\/302582","volume":"65","author":"I Schrijver","year":"1999","unstructured":"Schrijver, I., Liu, W., Brenn, T., Furthmayr, H. & Francke, U. Cysteine substitutions in epidermal growth factor-like domains of fibrillin-1: distinct effects on biochemical and clinical phenotypes. Am J Hum Genet 65, 1007\u20131020 (1999).","journal-title":"Am J Hum Genet"},{"key":"BFsrep33002_CR18","doi-asserted-by":"crossref","unstructured":"Arslan-Kirchner, M. et al. Clinical utility gene card for: Marfan syndrome type 1 and related phenotypes [FBN1]. Eur J Hum Genet 18 (2010).","DOI":"10.1038\/ejhg.2010.42"},{"key":"BFsrep33002_CR19","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.cca.2016.02.005","volume":"456","author":"M Luo","year":"2016","unstructured":"Luo, M. et al. Genetic testing of 10 patients with features of loeys-dietz syndrome. Clin Chim Acta 456, 144\u2013148 (2016).","journal-title":"Clin Chim Acta"},{"key":"BFsrep33002_CR20","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1186\/1756-0500-6-456","volume":"6","author":"K Uike","year":"2013","unstructured":"Uike, K. et al. Systemic vascular phenotypes of Loeys-Dietz syndrome in a child carrying a de novo R381P mutation in TGFBR2: a case report. BMC Res Notes 6, 456 (2013).","journal-title":"BMC Res Notes"},{"key":"BFsrep33002_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0002-9149(00)80066-1","volume":"75","author":"DI Silverman","year":"1995","unstructured":"Silverman, D. I. et al. Life expectancy in the Marfan syndrome. Am J Cardiol 75, 157\u2013160 (1995).","journal-title":"Am J Cardiol"},{"key":"BFsrep33002_CR22","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.jacc.2015.01.040","volume":"65","author":"AM Bertoli-Avella","year":"2015","unstructured":"Bertoli-Avella, A. M. et al. Mutations in a TGF-beta ligand, TGFB3, cause syndromic aortic aneurysms and dissections. J Am Coll Cardiol 65, 1324\u20131336 (2015).","journal-title":"J Am Coll Cardiol"},{"key":"BFsrep33002_CR23","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.ajhg.2014.10.018","volume":"95","author":"M Barbier","year":"2014","unstructured":"Barbier, M. et al. MFAP5 loss-of-function mutations underscore the involvement of matrix alteration in the pathogenesis of familial thoracic aortic aneurysms and dissections. Am J Hum Genet 95, 736\u2013743 (2014).","journal-title":"Am J Hum Genet"},{"key":"BFsrep33002_CR24","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ajhg.2014.11.015","volume":"96","author":"DC Guo","year":"2015","unstructured":"Guo, D. C. et al. MAT2A mutations predispose individuals to thoracic aortic aneurysms. Am J Hum Genet 96, 170\u2013177 (2015).","journal-title":"Am J Hum Genet"},{"key":"BFsrep33002_CR25","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1161\/CIRCRESAHA.115.307130","volume":"118","author":"DC Guo","year":"2016","unstructured":"Guo, D. C. et al. LOX Mutations Predispose to Thoracic Aortic Aneurysms and Dissections. Circ Res 118, 928\u2013934 (2016).","journal-title":"Circ Res"},{"key":"BFsrep33002_CR26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/gim.2014.91","volume":"17","author":"LM Baudhuin","year":"2015","unstructured":"Baudhuin, L. M., Kotzer, K. E. & Lagerstedt, S. A. Increased frequency of FBN1 truncating and splicing variants in Marfan syndrome patients with aortic events. Genet Med 17, 177\u2013187 (2015).","journal-title":"Genet Med"},{"key":"BFsrep33002_CR27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17, 405\u2013424 (2015).","journal-title":"Genet Med"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep33002.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep33002","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep33002.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T01:26:21Z","timestamp":1672881981000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep33002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,9]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,16]]}},"alternative-id":["BFsrep33002"],"URL":"https:\/\/doi.org\/10.1038\/srep33002","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,9]]},"assertion":[{"value":"19 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33002"}}